16-81096217-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000315467.9(GCSH):c.62C>T(p.Ser21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.797 in 149,294 control chromosomes in the GnomAD database, including 48,741 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000315467.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCSH | NM_004483.5 | c.62C>T | p.Ser21Leu | missense_variant | 1/5 | ENST00000315467.9 | NP_004474.2 | |
GCSH | XM_017023136.3 | c.62C>T | p.Ser21Leu | missense_variant | 1/5 | XP_016878625.1 | ||
GCSH | NR_033249.2 | n.179C>T | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCSH | ENST00000315467.9 | c.62C>T | p.Ser21Leu | missense_variant | 1/5 | 1 | NM_004483.5 | ENSP00000319531 | P1 |
Frequencies
GnomAD3 genomes AF: 0.797 AC: 118919AN: 149186Hom.: 48732 Cov.: 34
GnomAD3 exomes AF: 0.540 AC: 696AN: 1288Hom.: 61 AF XY: 0.552 AC XY: 428AN XY: 776
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.642 AC: 671291AN: 1045944Hom.: 156214 Cov.: 32 AF XY: 0.647 AC XY: 327531AN XY: 506550
GnomAD4 genome AF: 0.797 AC: 118945AN: 149294Hom.: 48741 Cov.: 34 AF XY: 0.793 AC XY: 57799AN XY: 72908
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Non-ketotic hyperglycinemia Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
GCSH-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 25, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at